Mumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received ...

In Novartis Pharms. Corp. v. Torrent Pharma Inc., the U. S. Court of Appeals for the Federal Circuit shut down efforts to market a generic version of the heart disease drug ENTRESTO which is sold ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a legal complaint from Novartis seeking to block its launch. In August, a Delaware ...

The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...

MSN Pharma was given FDA approval for its Entresto (sacubitril and valsartan) generic on 24th July, prompting a lawsuit from Novartis claiming patent infringement and seeking a preliminary ...

Doses were titrated over 6 months (daily maximums, 160 mg and 10 mg, respectively), and agents from other drug classes were ... treatment previously. Valsartan's manufacturer sponsored the trial.

The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s ...

Indian Biotechnology firm Biocon has received approval of its ANDA for Sacubitril/Valsartan Tablets from the US Food and Drug ...

In a Jan. 10 precedential ruling by the United States Court of Appeals for the Federal Circuit, the validity of the U.S. patent covering ...

Lupin receives US FDA approval for sacubitril and valsartan tablets: Our Bureau, Mumbai Friday, January 24, 2025, 15:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announc ...

Discover all the brand names or Trade names of generic drug called Valsartan. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...